Crossmark

Statistical analysis plan for the COMPARE trial: a 3-arm randomised controlled trial comparing the effectiveness of Constraint-induced Aphasia Therapy Plus and Multi-modality Aphasia Therapy to usual care in chronic post-stroke aphasia (COMPARE)

Crossref DOI link: https://doi.org/10.1186/s13063-021-05238-0

Published Online: 2021-04-23

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rose, Miranda L. https://orcid.org/0000-0002-8892-0965
Rai, Tapan

Copland, David

Nickels, Lyndsey

Togher, Leanne

Meinzer, Marcus

Godecke, Erin

Kim, Joosup

Cadilhac, Dominique A.

Hurley, Melanie

Wilcox, Cassie

Carragher, Marcella
Funding

Funding for this research was provided by:

National Health and Medical Research Council (1083010)
License Information

Text and Data Mining valid from 2021-04-23

Version of Record valid from 2021-04-23
More Information

Article History

Received: 17 September 2020

Accepted: 30 March 2021

First Online: 23 April 2021

Declarations

:

: The Human Ethics Committee of the Gold Coast University Hospital, Queensland provided approval for the conduct of the COMPARE study (HREC/15/QGC/291). All participants gave written informed consent for participating in the COMPARE study.

: The final version of this statistical analysis plan was approved by the Executive Committee on June 22nd 2020.

: The authors declare they have no competing interests.

Document is current

Any future updates will be listed below